The authors concluded that the ERO-α enzyme contributes to the suppression of anti-tumor immunity by regulating G-CSF cytokines and CXCL1/2 via facilitating proteins folding, suggesting that inhibition of the ERO-α enzyme may difficult cancer progression. Here, CXCL1 is linked to cancer.